Css LLC Gilead Sciences, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.43 Million - $1.61 Million	-24,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.44 Million - $1.8 Million	24,800 New	24,800 $1.48 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.63 Million - $1.9 Million	-22,600 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $1.42 Million - $1.81 Million	22,600 New	22,600 $1.69 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.